FI894580A0 - Non-a, non-b -hepatitisvirusantigenpeptid. - Google Patents

Non-a, non-b -hepatitisvirusantigenpeptid.

Info

Publication number
FI894580A0
FI894580A0 FI894580A FI894580A FI894580A0 FI 894580 A0 FI894580 A0 FI 894580A0 FI 894580 A FI894580 A FI 894580A FI 894580 A FI894580 A FI 894580A FI 894580 A0 FI894580 A0 FI 894580A0
Authority
FI
Finland
Prior art keywords
hepatitis
virus antigen
hepatitis virus
antigen peptides
antigen peptide
Prior art date
Application number
FI894580A
Other languages
English (en)
Other versions
FI894580A (fi
Inventor
Terukatsu Arima
Konosuke Fukai
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1193233A external-priority patent/JP2696116B2/ja
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of FI894580A0 publication Critical patent/FI894580A0/fi
Publication of FI894580A publication Critical patent/FI894580A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI894580A 1988-09-30 1989-09-27 Non-a, non-b -hepatitisvirusantigenpeptid. FI894580A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP24717588 1988-09-30
JP5264289 1989-03-04
JP15325789 1989-06-14
JP1193233A JP2696116B2 (ja) 1988-09-30 1989-07-25 非ａ非ｂ肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするｄｎａ

Publications (2)

Publication Number Publication Date
FI894580A0 true FI894580A0 (fi) 1989-09-27
FI894580A FI894580A (fi) 1990-03-31

Family

ID=27462798

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894580A FI894580A (fi) 1988-09-30 1989-09-27 Non-a, non-b -hepatitisvirusantigenpeptid.

Country Status (12)

Country Link
US (2) US5191064A (fi)
EP (1) EP0363025B1 (fi)
AT (1) ATE154391T1 (fi)
AU (1) AU623433B2 (fi)
CA (1) CA1341089C (fi)
DE (1) DE68928119T2 (fi)
DK (1) DK480889A (fi)
FI (1) FI894580A (fi)
HU (1) HUT58805A (fi)
MY (1) MY104208A (fi)
NO (1) NO893894L (fi)
NZ (1) NZ230560A (fi)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
ES2166749T3 (es) * 1989-05-18 2002-05-01 Chiron Corp Diagnosticos de nanbv: polinucleotidos utiles para discriminar virus de la hepatitis c.
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
HUT56883A (en) * 1989-12-18 1991-10-28 Wellcome Found Process for producing virus polypeptides
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
JPH0436185A (ja) * 1990-03-28 1992-02-06 Kyowa Hakko Kogyo Co Ltd 融合抗原ポリペプチド
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
JP3050395B2 (ja) * 1990-06-12 2000-06-12 国立感染症研究所長 Ｃ型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
NZ238681A (en) * 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
EP0551275B1 (en) * 1990-06-30 1994-12-21 Akzo Nobel N.V. Non-a non-b sequences
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
US7863008B2 (en) 1990-08-25 2011-01-04 Bioprocess Pty Ltd. Method for detecting NANBV associated seroconversion
AU673135B2 (en) * 1990-08-25 1996-10-31 New York Blood Center, Inc., The Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines
ES2070415T3 (es) * 1990-10-05 1995-06-01 Akzo Nobel Nv Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
ATE206717T1 (de) * 1990-11-03 2001-10-15 Dade Behring Marburg Gmbh Hcv-spezifische peptide, mittel dazu und ihre verwendung
US5654179A (en) * 1990-11-14 1997-08-05 Hri Research, Inc. Nucleic acid preparation methods
CA2082924A1 (en) * 1991-03-26 1992-09-27 David C. Leahy Assay for non-a non-b hepatitis
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0544861A4 (en) * 1991-06-13 1997-06-04 Baxter Diagnostics Inc Immunoassay for non-a non-b hepatitis
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
ZA927837B (en) * 1991-10-15 1994-03-11 Akzo Nv Monoclonal antibodiesto hepatitis C virus
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5437974A (en) * 1992-02-04 1995-08-01 Dade International Inc DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
CA2142872A1 (en) * 1992-08-21 1994-03-03 Lieselotte Lennartz Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
US7666661B2 (en) 2001-08-27 2010-02-23 Platypus Technologies, Llc Substrates, devices, and methods for quantitative liquid crystal assays
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
AU2003299522B2 (en) * 2002-05-22 2008-03-06 Platypus Technologies, Llc Substrates, devices, and methods for cellular assays
US8268614B2 (en) 2002-05-22 2012-09-18 Platypus Technologies, Llc Method for assaying cell movement
WO2005012872A2 (en) * 2003-07-25 2005-02-10 Platypus Technologies, Llc Liquid crystal based analyte detection
US7662572B2 (en) 2005-08-25 2010-02-16 Platypus Technologies, Llc. Compositions and liquid crystals
US7842499B2 (en) * 2006-08-07 2010-11-30 Platypus Technologies, Llc Substrates, devices, and methods for cellular assays
EP2193365A4 (en) 2007-08-20 2015-05-13 Platypus Technologies Llc IMPROVED DEVICES FOR CELL TESTS
WO2010031047A2 (en) * 2008-09-15 2010-03-18 Platypus Technologies, Llc Detection of vapor phase compounds by changes in physical properties of a liquid crystal

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) * 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
WO1982002774A1 (en) * 1981-02-11 1982-08-19 Baxter Travenol Lab Non-a,non-b hepatitis virus
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) * 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58753A (ja) * 1981-06-25 1983-01-05 Eisai Co Ltd 非ａ非ｂ型肝炎関連抗体および検出試薬
US4438098A (en) * 1982-01-27 1984-03-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Heat treatment of a non-A, non-B hepatitis agent to prepare a vaccine
JPS58183629A (ja) * 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
EP0093438B1 (en) * 1982-05-05 1988-07-20 Louisiana State University and Agricultural and Mechanical College Non-a, non-b hepatitis antigen
EP0119259A4 (en) * 1982-09-16 1988-08-04 Gen Hospital Corp NOT A, NOT B, HEPATITIS VIRUS, METHOD FOR DETERMINATION, CLEANING, LABELING, DIAGNOSIS AND IMMUNIZATION.
CA1207662A (en) * 1982-12-02 1986-07-15 Ricardo H. Landaburu Hepatitis b and non-a-non-b-safe biological products
DE3316464A1 (de) * 1983-05-05 1984-11-08 Heinrich Prof Dr Med Liehr Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
JPS60176600A (ja) * 1984-02-24 1985-09-10 Fujimoto Rinshiyou Kensa Kenkyusho:Kk グアナ−ゼ活性測定方法
ZA8410091B (en) * 1984-03-02 1985-08-28 Warner Lambert Co Detection of non-a,non-b hepatitis
JPS6125484A (ja) * 1984-07-16 1986-02-04 Isao Ono 抗体を産生する細胞株
JPS6156196A (ja) * 1984-07-16 1986-03-20 Isao Ono モノクロ−ナル抗体
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
JPS61176856A (ja) * 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非ａ非ｂ型肝炎抗原
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
JPS62181798A (ja) * 1986-02-06 1987-08-10 Isao Ono モノクロ−ナル抗体
JPS6391328A (ja) * 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎抗原
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
JPH04501203A (ja) * 1988-07-06 1992-03-05 ジェネラブズ　インコーポレイティド 後―輸血性，非―ａ，非―ｂ型肝炎ウィルス及び抗原
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
CA1341089C (en) 2000-08-22
US5298394A (en) 1994-03-29
AU4179989A (en) 1990-04-05
EP0363025B1 (en) 1997-06-11
MY104208A (en) 1994-02-28
FI894580A (fi) 1990-03-31
DK480889D0 (da) 1989-09-29
ATE154391T1 (de) 1997-06-15
NZ230560A (en) 1992-05-26
EP0363025A2 (en) 1990-04-11
HUT58805A (en) 1992-03-30
DE68928119D1 (de) 1997-07-17
NO893894L (no) 1990-04-02
EP0363025A3 (en) 1990-04-25
DK480889A (da) 1990-04-02
DE68928119T2 (de) 1998-01-08
NO893894D0 (no) 1989-09-29
AU623433B2 (en) 1992-05-14
US5191064A (en) 1993-03-02

Similar Documents

Publication Publication Date Title
FI894580A (fi) Non-a, non-b -hepatitisvirusantigenpeptid.
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
ATE194844T1 (de) Hepatitis c-virus-epitope
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
EP0442394A3 (en) Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
ATE125821T1 (de) Vakzin gegen hepatitis b.
ATE170220T1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
ES2170152T3 (es) Virus de la hepatitis g y clon molecular del mismo.
Tabor et al. REMOVAL OF HEPATITIS-B-VIRUS INFECTIVITY FROM FACTOR-IX COMPLEX BY HEPATITIS-B IMMUNE-GLOBULIN: Experiments in Chimpanzees
NO950977L (no) Nye forgrenede hydrid- og klasepeptider som er effektive ved diagnostisering og påvisning av ikke-A, ikke-B hepatit
WO2004005316A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
EP0516859A4 (fi)
CA2080213A1 (en) Diagnostic reagent for hepatitis c
ATE117696T1 (de) Mit antikörper gegen hepatitis-virus non-a, non-b immunochemisch reagierende peptide.
EP0250128A3 (en) Novel virus isolated from patients with aids
SE9002671L (sv) Nya peptider, diagnostiska antigener, anvaendning daerav och vacciner
TH7280A (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
IT1270941B (it) Peptidi di hcv e loro usi.
TH7280EX (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
TH9844EX (th) เพพไทด์ที่สัมพันธุ์ hiv
IT1273996B (it) Uso di anticorpi che riconoscono la proteina 90k nella diagnostica clinica e nel monitoraggio dei pazienti affetti da epatite virale
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: THE RESEARCH FOUNDATION FOR MICROBIAL